We searched for chromosome 3p homo-and hemizygous losses in 23 lung cancer cell lines, 53 renal cell and 22 breast carcinoma biopsies using 31 microsatellite markers located in frequently deleted 3p regions. In addition, two sequence-tagged site markers (NLJ-003 and NL3-001) located in the Alu-PCR clone 20 region (AP20) and lung cancer (LUCA) regions, respectively, were used for quantitative real-time PCR (QPCR). We found frequent (10-18%) homozygous deletions (HDs) in both 3p21.3 regions in the biopsies and lung cancer cell lines. In addition, we discovered that amplification of 3p is a very common (15-42.5%) event in these cancers and probably in other epithelial malignancies. QPCR showed that aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of all studied cases. HDs were frequently detected simultaneously both in NLJ-003 or NL3-001 loci in the same tumour (Po3-10 À7 ). This observation suggests that tumour suppressor genes (TSG) in these regions could have a synergistic effect. The exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies are located very near to these markers. Precise mapping of 15 independent HDs in the LUCA region allowed us to establish the smallest HD region in 3p21.3C located between D3S1568 (CACNA2D2 gene) and D3S4604 (SEMA3F gene). This region contains 17 genes. Mapping of 19 HDs in the AP20 region resulted in the localization of the minimal region to the interval flanked by D3S1298 and D3S3623 markers. Only four genes were discovered in this interval, namely, APRG1, ITGA9, HYA22 and VILL.
We searched for chromosome 3p homo-and hemizygous losses in 23 lung cancer cell lines, 53 renal cell and 22 breast carcinoma biopsies using 31 microsatellite markers located in frequently deleted 3p regions. In addition, two sequence-tagged site markers (NLJ-003 and NL3-001) located in the Alu-PCR clone 20 region (AP20) and lung cancer (LUCA) regions, respectively, were used for quantitative real-time PCR (QPCR). We found frequent (10-18%) homozygous deletions (HDs) in both 3p21.3 regions in the biopsies and lung cancer cell lines. In addition, we discovered that amplification of 3p is a very common (15-42.5%) event in these cancers and probably in other epithelial malignancies. QPCR showed that aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of all studied cases. HDs were frequently detected simultaneously both in NLJ-003 or NL3-001 loci in the same tumour (Po3-10 À7 ). This observation suggests that tumour suppressor genes (TSG) in these regions could have a synergistic effect. The exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies are located very near to these markers. Precise mapping of 15 independent HDs in the LUCA region allowed us to establish the smallest HD region in 3p21.3C located between D3S1568 (CACNA2D2 gene) and D3S4604 (SEMA3F gene). This region contains 17 genes. Mapping of 19 HDs in the AP20 region resulted in the localization of the minimal region to the interval flanked by D3S1298 and D3S3623 markers. Only four genes were discovered in this interval, namely, APRG1, ITGA9, HYA22 and VILL.
Introduction
Epithelial tumours cause more than 80% of all cancerrelated deaths. For example, lung cancer alone kills 4150 000 patients each year in USA and many more around the world. Loss of heterozygosity (LOH) involving several chromosome 3p regions accompanied by chromosome 3p deletions is a characteristic feature of major epithelial cancers/carcinomas (MEC). Six of the MEC where 3p deletions are especially high, that is, lung, breast, cervical, oral cavity, ovary and kidney, cause 34% of all cancer-related deaths (Stewart and Kleihues, 2003) . 3p deletions are detected in almost 100% of small-cell lung cancer (SCLC), renal cell carcinoma (RCC) and more than 80% of breast carcinomas (BCs) (Van den Berg and Braga et al., 1999 Braga et al., , 2002 Wistuba et al., 2000 Wistuba et al., , 2001 . In addition, these changes appear early in the pathogenesis of cancers (Kok et al., 1997; Zabarovsky et al., 2002) . These 3p genetic alterations lead to the conclusion that the short arm of human chromosome 3 contains several TSGs. Although the first data, suggesting 3p alterations in lung, kidney and other MEC, were published more than 15 years ago (Kok et al., 1997) , only recently has significant progress been achieved in identifying resident candidate TSGs and their functional role in tumour pathogenesis . Development of MEC is a complex process involving sometimes more than 20 genes from different chromosomes (Zo¨chbauer-Muller et al., 2002) . We know that human chromosome 3 contains several tumour suppressor genes (TSGs), some of which are cancer specific and others are common for different cancer types (Van den Berg and Buys, 1997; Braga et al., 1999 Braga et al., , 2002 Wistuba et al., 2000 Wistuba et al., , 2001 . Identification and precise localization of these TSGs on human chromosome 3p would facilitate rapid progress in our understanding of cancer gene models. Previously, during deletion mapping allelic imbalance (AI) was considered as LOH that marked the position of a TSG. However, AI could result from simultaneous amplification of some 3p21.3 regions marking the presence of potential oncogenes (Angeloni and Lerman, 2001; Senchenko et al., 2003) .
Homozygous deletions (HD) are excellent indicators of the locations of TSGs and several of these have been described in seven regions of chromosome 3 . However, microsatellite deletion mapping is not well suited for the detection of such deletions due to the normal cell contamination. Balance between two alleles does not change in such cases and deletion will go undetected. In fact, this can lead to paradoxical results when LOH in homozygously deleted regions may be less than in surrounding regions.
In summary, our and others' results led to the conclusion that chromosome 3 harbours several TSGs and these could be important in several different tumour types. We have performed LOH analysis of more than 400 MEC samples (Braga et al., , 2002 Alimov et al., 2000; Senchenko et al., 2003) and found that two 3p21.3 regions (lung cancer region (LUCA) at the centromeric and Alu-PCR clone 20 region (AP20) at the telomeric borders of 3p21.3) are the most frequently affected regions (FARs).
We have constructed detailed physical maps and sequenced these regions (Wei et al., 1996; Protopopov et al., 2003) . In order to localize precisely TSG and make more accurate deletion mapping, we first (as a test case) performed combined deletion mapping of these regions in cervical carcinomas (CC) using LOH with microsatellite markers and quantitative real-time PCR (QPCR) (Senchenko et al., 2003) . The results demonstrated usefulness of QPCR and suggested that TSG(s) involved in the development of CC were located very near to NLJ-003 (D3S1642) and NL3-001 (D3S3874) as aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of studied cases.
In the present work, we discovered frequent HDs in major human cancers affecting previously mapped 3p21.3 regions and also demonstrated that aberrations in 3p21.3 were complex and, in addition to deletions, may involve gene amplifications as well.
Results and discussion

QPCR for detection copy number changes
We have shown earlier (Senchenko et al., 2003) that this approach permits the detection of the difference in X chromosome copy number between males (one copy) and females (two copies). However, this method should be used with caution as cancer cells usually show numerous chromosomal abnormalities leading to copy number changes of many genes including reference genes. That is why the most important cases including samples with HDs used for fine localization of the minimal homozygously deleted regions were tested with different reference genes, ACBT, phospho-fructo-2 kinase gene (PF2K) and NotI linking clone 924À021 (3p12.3Àp13), containing an unknown gene.
In the majority of cases, results with different reference genes were very similar (see Table 1 ). Cases showing different relative DNA copy number with different reference genes were not considered in the paper.
QPCR results for RCC, BC and SCLC samples and cell lines
Schematic map of the AP20 and LUCA regions is shown in Figure 1 .
The results of the experiments are shown in Tables 2-4. Summary of these data, including previously published results on CC samples (Senchenko et al., 2003) , are shown in Table 5 .
Using only two markers, NLJ-003 and NL3-001, aberrations can be detected in more than 90% of studied cancers. These results are even more remarkable as the published LOH level for BC and CC is lower even using many microsatellite markers (80 and 75%, respectively; Braga et al., 2002) . These results strongly support the suggestion that these two regions are real hot spots for rearrangements in MEC.
In general, both AP20 and LUCA regions showed similar pattern and frequency of aberrations. Some differences were still possible to observe. For instance, the frequency of hemizygous deletions in AP20 region was slightly higher than in LUCA region, but it is easy to understand as many deletions are terminal and AP20 is located closer to the telomere. The highest frequency of hemizygous deletions was detected in SCLC: 60.9% in NLJ-003 and 60% in NL3-001. Most likely, this results from the use of tumour cell lines. The highest fraction of HDs in NLJ-003 was detected in CC (15.6%) and for NL3-001 it happened in 18% of BC cases.
The highest fraction of amplification was detected for both loci in RCC: 34% in NLJ-003 and 42.5% in NL3-001. To confirm that amplification is a common event in RCC, we performed additional experiments with five RCC cell lines showing LOH and considered to have 3p deletions (Alimov et al., 2000) . However, cytogenetic analysis demonstrated that among them only A498 had two copies of chromosome 3 and four lines had from three to five copies (KRC/Y, HN51, CAKI1 and TK164). Nevertheless, all these five lines revealed only one marker in LOH analysis arguing that one 3p arm was lost.
Owing to limited amount of tumour DNA it was not possible to test amplified samples by Southern hybridization. However, multiplex PCR with microsatellite markers clearly proved that amplification indeed occurred in some samples and even could be seen in the same samples where other regions of 3p are deleted (Figure 2 ). (Senchenko et al., 2003) , a correlation over 85% between real-time PCR and LOH data was observed in both loci. We considered results as inconsistent if nearest microsatellite markers from both sides showed results incompatible with QPCR data. For instance, RCC sample #10 in Figure 3 revealed amplification in NL3-001 locus. However, both D3S3615 and D3S3667 loci showed retention. These discordant results can be explained by different factors (see Senchenko et al., 2003) . For example, the previous case could be explained by a duplication of both chromosomes 3. The most important reason for disagreements is different locations of microsatellite and QPCR markers and occurrence of chromosomal breakpoints between the markers.
Cases with HDs were further mapped more precisely
In all, 19 tumours having HDs in the AP20 region were additionally mapped with D3S1611, D3S2417, D3S3623 and INTR1H22 (see examples in Figure 5 ). The smallest region homozygously deleted in AP20 was flanked by D3S1298 and D3S3623 (Figure 1 ). RCC cases #27 and The range given for the probes was determined as 2 ÀDDCT with DDC T +s and DDC T Às, where s is the standard deviation of the DDC T value (see #35 showed a breakpoint at D3S1298. RCC sample #46 had a breakpoint at D3S2417 and #33 at D3S3623. BC cases 4 and 6 had telomeric breakpoint at D3S2417 and centromeric breakpoint at D3S1298. Lung cancer cell lines H1693 and H1688 had centromeric breakpoints at D3S1298.
A total of 15 tumours with HDs in NL3-001 were mapped using additional markers: D3S1568, D3S4614, D3S2968, D3S4597, D3S4604, 5 0 SEMA5 and D3S1573 (see examples in Figure 5a ).
The smallest region homozygously deleted in LUCA was bordered by D3S1568 and D3S4604 (Figure 1 ). Several samples, for example, RCC #33 and #8, proved that the centromeric border is inside the CACNA2D2 gene. The telomeric border is inside the SEMA3F gene (D3S4604) for RCC #33 and BC #4 and #6.
Complex 3p rearrangements in MEC
This study has again highlighted the complex character of chromosomal rearrangements in 3p during the development of epithelial tumours. In addition to homoand hemizygous deletions, duplication/amplification of the whole chromosome 3 or some regions were frequently (15-42.5%) detected. Thus, amplification of 3p is very common in studied cancers and probably in all MEC. Therefore, microsatellite deletion data should be evaluated carefully as AIs signify not only LOH but also amplification. It is important to mention that not all cases of multiplication will be detected by microsatellite analysis as AI. Allele titration experiments revealed significant bias for the detection of LOH for the H-(high-molecular-weight) allele compared to L-(lowmolecular-weight) allele. In general, AI in cases of L-allele deletions can be detected only if the content of an L-allele in DNA is less than 30% . Simple calculations for the chromosome duplication Samples showed multiplication are in underlined bold italics and samples with white letters contained hemizygous deletions. c Alleles were taken as homozygously deleted if the highest value of the calculated range was below 0.5 and hemizygously deleted if this value was below 1.0. An allele was considered as amplified/ multiplied if the lowest value of the range was over 1.0 ND ¼ not determined Samples showed multiplication are in underlined bold italics and samples with white letters contained hemizygous deletions. c Alleles were taken as homozygously deleted if the highest value of the calculated range was below 0.5 and hemizygously deleted if this value was below 1.0. An allele was considered as amplified/ multiplied if the lowest value of the range was over 1.0 3p deletion hot-spots in epithelial tumours VN Senchenko et al (two copies of L-and H-alleles) and triplication (three copies of each allele) cases as it was carried out in Liu et al., (1999) showed that AI could not be revealed for the majority of cases if one or two copies of L-allele would be deleted, respectively. One tentative explanation of these phenomena might be that inactivated TSG(s) were amplified together with neighbouring proto-oncogenes/oncogenes. Human chromosome 3p contains many genes that can play a dominant oncogenic role. The MST1 receptor (RON) and its ligand MST1 gene are located in 3p21, and their overproduction can result in autocrine stimulation and uncontrolled proliferation (Angeloni and Lerman, 2001) . Therefore, in addition to the deletion of TSGs amplification of some 3p21.3 regions could reflect increased activity of resident potential oncogenes (Senchenko et al., 2003) .
Six pairs of tumour/normal DNA samples (BC 1, 2, 7, 11 and RCC 39, 42) that showed amplification of NL3-001 were analysed with the SSCP method to look for mutations in the kinase domain of the receptor tyrosine kinase RON . This gene is located closely telomeric to the LUCA region. No mutations were found but single-nucleotide polymorphisms (SNP) in intron 18 and exon 20 were found. Sample 11 was found heterozygous for an intronic C to A transversion of an SNP located 10 bp upstream the intron/exon splice site between intron 18 and exon 19 consistent with amplification.
To understand the possible effect of this base change on the splicing process, we looked for possible splicing variants of exon 19 in a cell line homozygous for the C to A mutation. The lung cancer cell line NCI-H1650, out of several analysed by SSCP, was found homozygous; mRNA extracted from these cells was retrotranscribed into cDNA and amplified with PCR primers specific for the region of interest (primers: ex18Fw and 5Rv, see Angeloni et al., 2003) . The PCR Samples showed multiplication are in underlined bold italics and samples with white letters contained hemizygous deletions.
c Alleles were taken as homozygously deleted if the highest value of the calculated range was below 0.5 and hemizygously deleted if this value was below 1.0. An allele was considered as amplified/multiplied if the lowest value of the range was over 1.0 ND ¼ not determined Thus, it is possible to suggest that amplified allele has some different features than the wild-type allele and this could facilitate malignant progression. Indeed, it was recently found that activated RON is involved in some lung cancers (Danilkovitch-Miagkova et al., 2003) .
Another striking observation made in this study is the finding of very high level of HDs in both LUCA and AP20 regions, amounting to more than 10%. As it was shown in our previous study, the results of QPCR are highly reliable (Senchenko et al., 2003) . Figure 5 demonstrates that results of QPCR are concordant to the PCR and Southern results.
QPCR data for NLJ-003 and NL3-001 loci were combined with LOH data to localize precisely positions of candidate TSGs. Figure 3 Combination of LOH and QPCR data for 3p deletion mapping of RCC samples. Black squares represent LOH and HDs; white squares, retention of heterozygosity and normal copy number; gray squares, multiplication; striped boxes, noninformative cases. L and H inside black squares denote the type of allele lost. It was shown that the H-allele is less sensitive to normal cell contamination than L-allele 3p deletion hot-spots in epithelial tumours VN Senchenko et al In all, 19 tumours having HD in AP20 region and 15 tumours with HDs in NL3-001 were carefully mapped using 11 additional microsatellite markers (see smallest homozygously deleted regions in Figure 1 ). The data obtained in this study are very similar to the results for CC (Senchenko et al., 2003) .
The smallest region homozygously deleted in LUCA is bordered by D3S1568 and D3S4604. Therefore, the centromeric border is inside the CACNA2D2 gene. The telomeric border is inside the SEMA3F gene for all four different types of tested MEC.
This implies that the TSG(s) located centromeric to CACNA2D2 and telomeric to SEMA3F could be excluded from the list of candidate TSG(s) in these malignancies.
The results confirm earlier suggestion that both SEMA genes should be considered candidate TSGs Senchenko et al., 2003) .
As more markers were used in this study in AP20 region compared to the analysis of CC samples, it was possible to significantly narrow down the location of candidate TSGs. The smallest region homozygously deleted in AP20 was flanked by D3S1298 and D3S3623. Thus, only four known genes can still be considered as candidate TSGs: APRG1, ITGA9, HYA22 and VILL. This analysis excludes DLEC1 and MYD88 (Daigo et al., 1999; Protopopov et al., 2003) as candidate TSG(s) involved in the studied cancers. Comparing results of this and a previous study (Senchenko et al., 2003) with that of Daigo et al., (1999) , who studied the HD in SCLC cell line ACC-LC5, several conclusions can be drawn. HDs around NLJ-003 were common in different MEC, including SCLC, non-small-cell lung cancer (NSCLC), RCC, BC and CC. After deletion mapping of ACC-LC5, three genes were suggested as candidate TSGs: GOLGA4, ITGA9 and HYA22; however, none of them had TSG function demonstrated. Our data exclude GOLGA4 from the candidates but add APRG1 and VILL genes . Our preliminary data suggest that sequences for HYA22 and VILL genes that have been determined mainly in silico (Ishikawa et al., 1997; Daigo et al., 1999) were not correct. We found additional coding exons and new initiating ATG codons. Recently, we discovered (Kashuba et al., 2004) that some of the newly discovered splice variants of the HYA22 gene (renamed RBSP3, RB1 serine phosphatase from chromosome 3) have growth inhibiting activity both in vitro and in vivo, and were frequently mutated in many tumour types. Additional studies are needed to clarify as to whether other candidate genes in the AP20 region have also TSG activity.
We have shown earlier that the AP20 region is heavily methylated in all studied RCC cell lines, suggesting that hypermethylation of TSG(s) in this region may play a critical role similar to the situation in the LUCA region. Moreover, genes in Figure 4 Combination of LOH and QPCR data for 3p deletion mapping of BC samples. The designations are the same as in Figure 3 3p deletion hot-spots in epithelial tumours VN Senchenko et al the region have multiple splicing forms and both mutation or functional analyses of such genes represent a difficult task. Thus, AP20 region may be similar to LUCA region and contains several TSGs.
It was suggested that aberrations in both LUCA and AP20 region could be causatively linked (Senchenko et al., 2003) . Indeed, HDs in both regions often happened in the same tumour (Po3 Â 10 À7 ); see for example, Figures 1, 3 , 4, 5a and Tables 2-4. The estimation of possible interdependency between all aberrations in loci NLJ-003 and NL3-001 as different events was carried out using a permutation test for all four types of studied MEC. This test also revealed a significant correlation between different aberrations in these two loci (Po10 À6 ).
The same results were obtained using Pearson's correlation for numeric values of copy number changes of these loci. Thus these analyses demonstrated that aberrations in both LUCA and AP20 regions occur simultaneously in the same tumour with high probability. We have reported previously (Braga et al., , 2002 ) that distribution of different deletion types showed tissue-specific differences, and thus some of the TSGs located in 3p could be important only for the development of particular malignancies, for example, VHL is involved almost exclusively in clear cell renal carcinomas Imreh et al., 2003) . However, we have also noted that LUCA and AP20 are the most FARs in RCC, SCLC, NSCLC, BC and CC (see Zabarovsky et al., 2002; Imreh et al., 2003 and other) . Therefore, we suggested that these two regions might contain TSGs involved in different types of cancers, that is, to represent multiple TSGs. This study supported this hypothesis. Moreover, we would expect that the same TSG could be implicated in several types of malignancies.
Finally, the exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies reside very near to these markers.
Materials and methods
DNA samples and Southern blot analysis
In all, 23 lung cancer cell lines (obtained from ATCC (Rockville, MD, USA)) and biopsy samples from 53 RCC and 22 BC were studied. Lung cancer cell lines were described previously (Phelps et al., 1996) . For histological verification top and bottom sections (5-mm thick) cut from frozen tumour tissues were examined after staining with haematoxylin and eosin. Selected samples containing 60% or more tumour cells and matched normal tissues were stored at À701C.
High-molecular-weight DNA was isolated with proteinasephenol treatment (Sambrook et al., 1989) .
Chromosome 3-specific NotI linking clones NLJ-003/ D3S1642 and NL3-001/D3S3874 (mapped to 3p21.3T and to 3p21.3C, respectively) were described previously (Kashuba et al., 1999) .
Southern blotting and hybridization were performed according to standard procedures. Band intensities were determined using a Molecular Dynamics Personal Densitometer SI (Sunnyvale, CA, USA) according to the manufacturer's protocol. NotI linking clone NL1-290/D3S4293 mapped to 3q13.3-q21 (Kashuba et al., 1999) was used as a reference control because this region usually does not reveal frequent AIs in carcinomas (Erlandsson, 1998; Girard et al., 2000; Lindblad-Toh et al., 2000; Yang et al., 2002) . The ratio of band intensities showing copy number changes of the probe NLJ-003 was calculated according to the formula: PT Â RN/ RT Â PN, where PT and PN were band intensities for the NLJ-003 bands, and RT and RN represented band intensities of NL1-290 in tumour and normal samples, respectively.
Karyotype analyses
The cell lines were karyotyped using the trypsin-Giemsa banding technique previously described in detail (Seabright, 1971) . Six metaphases were analysed for each cell line. ABI Prism s Model 7700 Sequence Detector and TaqMan probes (Applied Biosystems) were used in this study. Primer and TaqMan probe sequences for NLJ-003/D3S1642 and NL3-001/D3S3874 were described earlier (Senchenko et al., 2003) . The following sequences were designed for NotI linking clone 924-021/D3S1634 located at 3p12.3-p13 with amplicon of 52 bp: probe 5 0 -TGCTGGCCACAGGCCCTGC-3 0 , primer (F) 5 0 -TGCATGTGCCAGTGT-3 0 , primer (R) 5 0 -GTG-TTGTGAGCCCTGGGAA-3 0 . The probe was labeled with JOE (2,7-dimethoxy-4,5-dichloro-6-carboxy-fluoroscein) as reporter dye, located at the 5 0 -end. TAMRA (6-carboxy-N,N,N 0 ,N 0 -tetramethyl-rhodamine), conjugated to the 3 0 -end was used as a quencher. All probes and primers were purchased from Applied Biosystems (Foster City, CA, USA).
The validation experiments and primer limitation experiments were performed as described in detail (Senchenko et al., 2003) . PCR reactions were carried out in triplicate. All control experiments demonstrated that primers and probes designed for NLJ-003 and NL3-001 loci were appropriate for the comparative C T method (DDC T method). It was used for the quantification of marker copy numbers and has been shown to be precise enough to discriminate between two and one allele copies. The parameter C T (threshold cycle) is defined as the cycle number required for dye fluorescence to become higher than background fluorescence level. The method is based on the inverse exponential relationship that exists between initial quantity (copy number) of target sequence copies in the reactions and corresponding C T determinations -the higher the starting copy number of DNA target the lesser the C T value. This method was used to determine target sequence copy number in tumour DNA sample relative to the normal DNA from the same patient (calibrator) and relative to an endogenous control sequence (reference) -human aˆ-actin gene (ACTB), PF2K or 924-021/D3S1634 in both samples. The starting relative copy number DNA (at each locus in tumour sample) is given by 2 ÀDDCT , where
. Data were analysed using ABI Prism s 7700 Sequence Detection System software (version 1.7). The range given for the probes was determined as 2
ÀDDCT with DDC T þ s and DDC T Às, where s is the standard deviation of the DDC T value. According to histology analysis contamination of tumour samples with normal stroma and lymphocytes can reach up to 30-40%. Therefore, alleles were taken as homozygously deleted if the highest value of calculated range was below 0.5 and hemizygously deleted if this value was below 1.0. An allele was considered as amplified/multiplied if the lowest value of the range was over 1.0.
Polymorphic and sequence-tagged site (STS) markers and microsatellite analysis
A total of 26 polymorphic and two STS markers (NLJ-003/ D3S1642 and NL3-001/D3S3874) of 3p were described earlier (Senchenko et al., 2003) . Two STS nonpolymorphic markers were used to test two critical sites in 3p for copy number changes and HDs: the NLJ-003 (3p21.3T), residing in the AP20 HDs site (Kashuba et al., 1995; Ishikawa et al., 1997; Protopopov et al., 2003) and NL3-001 (3p21.3C), mapped to the LUCA HD site (Wei et al., 1996; .
Localization of D3S1611, D3S2417, D3S3623, D3S1642, INTR1H22, D3S1298, D3S3615, D3S2968, D3S4597, D3S4604, 5 0 SEMA5, D3S3874, D3S1568 and D3S4614 is shown in Figure 1 . 0 -CAGTGGGAACACCACTTCCT-3 0 . The PCR primers were purchased from Life Technologies/ Invitrogen (Carlsbad, CA, USA). The PCR and PAGE was carried out as described earlier .
Band intensities for PCR products of high-and lowmolecular-weight alleles were compared using a Molecular Dynamics Personal Densitometer SI. The LOH was scored when a ratio of intensities for matched tumour and normal DNAs differed two fold or more.
SSCP analysis
The radioactive reaction was performed in a total reaction volume of 12.5 ml, containing 100 ng of genomic DNA, 12.5 pmol of each primer, 200 mM dNTPs, 1.5 mM MgCl 2 , 1.25 nCi [a-35 S]dATP. Each primer pair (available upon request) amplifies a single band under the following cycling conditions: 3 min at 951C, then 1 min at 951C, 30 s at T ann (available upon request), 1 min at 721C for 35 cycles; and 7 min extension at 721C. After heat denaturation (8 min at 901C) in formamide buffer (Stop Solution, Amersham, Arlington Heights, IL, USA), PCR products were run overnight in a 0.5 Â MDE gel (FMC Bioproducts, Rockland, ME, USA), 0.6 Â TBE, at room temperature, 8 W constant power, transferred on 3 mm paper, dried and exposed to autoradiography film (X-OMAT AR, Kodak, Rochester, NY, USA).
Sequencing reactions were carried out automatically (ABI 373 Stretch Automated DNA Sequencer, Applied Biosystems, Foster City, CA, USA).
Abbreviations ACTB, human b-actin gene; AI, allelic imbalance; AP20, Alu-PCR clone 20 region; BC, breast carcinoma; C, centromeric; CC, cervical carcinoma; H-allele, high-molecular-weight allele; HD, homozygous deletion; L-allele, low-molecular-weight allele; LOH, loss of heterozygosity; LUCA, lung cancer region; MEC, major epithelial carcinomas; NSCLC, non-small cell lung cancer; PF2K, phosph-fructo-2 kinase gene; QPCR, quantitative real-time PCR; RCC, renal cell carcinoma STS, sequence-tagged site; SCLC, small-cell lung cancer; T, telomeric; TSG, tumour suppressor gene.
